Ketamine versus propofol for procedural sedation in pediatric pulsed dye laser therapy: a prospective randomized trial
Frontiers in Medicine · 30.04.2026 · 13
DOI: 10.3389/fmed.2026.1824892 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Frontiers in Medicine, online erschienen am 30.04.2026. Verfasst von Marija Stevic und 11 weiteren Autor:innen. Beteiligte Einrichtung: University Children's Hospital, Belgrade, Serbia. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pulsed dye laser (PDL) therapy is the gold standard for treating port-wine stains (PWS) in children but frequently requires procedural analgosedation due to pain and the need for immobility. The optimal sedative agent for repeated outpatient procedures remains unclear.
Objective
To compare the safety and efficacy of propofol- versus ketamine-based analgosedation in children undergoing PDL therapy, with a primary focus on respiratory depression.
Methods
In this prospective, randomized, controlled study, children aged 1–18 years (ASA I–II) were assigned to receive propofol or ketamine for PDL therapy. Standardized monitoring included electrocardiography, noninvasive blood pressure, pulse oximetry, and end-tidal CO₂. The primary outcome was respiratory depression, defined by predefined clinical and capnographic criteria. Secondary outcomes included hemodynamic instability, adverse events, drug consumption, procedural duration, sedation depth, and recovery time. Receiver operating characteristic (ROC) analysis was used to identify predictors of respiratory depression.
Results
A total of 310 procedures were analyzed. Respiratory depression was significantly more frequent in the propofol group compared with the ketamine group (19.5% vs. 2.6%, p < 0.01). Ketamine was associated with higher rates of hypertension, tachycardia, psychomimetic effects, and postoperative nausea and vomiting ( p < 0.01), whereas propofol was associated with more hypotension. Sedation and recovery times were longer with ketamine ( p < 0.01), while sedation depth was comparable between groups. A procedural duration ≥13.5 min predicted respiratory depression in the propofol group (AUC 0.755).
Conclusion
Both propofol and ketamine provide effective analgosedation for pediatric PDL therapy. Propofol is associated with a higher risk of respiratory depression, particularly during longer procedures, whereas ketamine offers greater respiratory stability but more other adverse effects. These findings support individualized anesthetic selection based on procedural duration and patient risk factors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Children's Hospital, Belgrade, Serbia.
- Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
- Faculty of Medicine, University of Nis, Niš, Serbia.
- University Clinical Center Nis, Nis, Serbia.
- Saints Cyril and Methodius University in Skopje Medical Faculty, Skopje, North Macedonia.
- Kent and Canterbury Hospital, Canterbury, United Kingdom.
Zitieren
APA
Stevic, M., Ristic, N., Budic, I., Trifunovic, B., Marjanovic, V., Bojic, S., Marković, D. Z., Jovanovski Srceva, M., Nenadic, D., Vlajkovic Ivanovic, A., Milic, L., & Nikolic, D. (2026). Ketamine versus propofol for procedural sedation in pediatric pulsed dye laser therapy: a prospective randomized trial. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1824892
Vancouver
Stevic M, Ristic N, Budic I, Trifunovic B, Marjanovic V, Bojic S, et al. Ketamine versus propofol for procedural sedation in pediatric pulsed dye laser therapy: a prospective randomized trial. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1824892
BibTeX
@article{Stevic2026,
author = {Stevic, Marija and Ristic, Nina and Budic, Ivana and Trifunovic, Branislav and Marjanovic, Vesna and Bojic, Suzana and Marković, Dejan Zivorad and Jovanovski Srceva, Marija and Nenadic, Dragan and Vlajkovic Ivanovic, Ana and Milic, Lazar and Nikolic, Dejan},
title = {Ketamine versus propofol for procedural sedation in pediatric pulsed dye laser therapy: a prospective randomized trial},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1824892}
}
EUVIMED